HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Zhao, L. Articles by Haslam, D. B Search for Related Content PubMed PubMed Citation Articles by Zhao, L. Articles by Haslam, D. B Agricola Articles by Zhao, L. Articles by Haslam, D. B

A quantitative and highly sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis

Departments of Pediatrics and Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63110, USA

Correspondence David B. Haslam haslam{at}kids.wustl.edu

Received April 29, 2005
Accepted July 8, 2005

Inhibition of protein synthesis is a common mechanism by which bacterial and plant toxins injure human cells. Examples of toxins that inhibit protein synthesis include shiga toxins of Escherichia coli, diphtheria toxin, Pseudomonas exotoxin A and the plant toxin ricin. In order to facilitate studies on toxin pathogenesis and to enable screening for inhibitors of toxin action, a quantitative and highly sensitive assay for the action of these toxins on mammalian cells was developed. The cDNA encoding destabilized luciferase was cloned into an adenoviral expression plasmid and a high-titre viral stock was prepared. Following transduction of Vero cells, luciferase expression was found to be linear with respect to viral multiplicity of infection. Luciferase expression by as few as 10 cells was readily detected. Treatment of transduced cells with either cycloheximide or shiga toxin resulted in a decrease in luciferase activity, with a half-life ranging from 1 to 2 h. Inhibition of luciferase expression was evident at toxin concentrations as low as 1 pg ml^–1. The assay was adapted for use in 24-, 96- and 384-well plates, enabling rapid processing of large numbers of samples. Using this approach, susceptibility of Vero, Hep2, Chang, A549, COS-1 and HeLa cells to three different toxins was determined. These results demonstrate that the luciferase-based assay is applicable to the study of numerous cell types, is quantitative, highly sensitive and reproducible. These features will facilitate studies on pathophysiology of toxin-mediated diseases and allow high-throughput screening for inhibitors of cytotoxicity.

This article has been cited by other articles:

				J. B. Saenz, T. A. Doggett, and D. B. Haslam Identification and Characterization of Small Molecules That Inhibit Intracellular Toxin Transport Infect. Immun., September 1, 2007; 75(9): 4552 - 4561. [Abstract] [Full Text] [PDF]

				C. Bachran, M. Sutherland, D. Bachran, and H. Fuchs Quantification of Diphtheria Toxin Mediated ADP-Ribosylation in a Solid-Phase Assay Clin. Chem., September 1, 2007; 53(9): 1676 - 1683. [Abstract] [Full Text] [PDF]

				Y. Kimura, M. Saito, Y. Kimata, and K. Kohno Transgenic Mice Expressing a Fully Nontoxic Diphtheria Toxin Mutant, not CRM197 Mutant, Acquire Immune Tolerance against Diphtheria Toxin J. Biochem., July 1, 2007; 142(1): 105 - 112. [Abstract] [Full Text] [PDF]